Image-guided resection of malignant gliomas using fluorescent nanoparticles

Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology

Volumn 5, Issue 3, 2013, Pages 219-232

  Su, Xinhui ^a,b   Cheng, Kai ^a   Wang, Charlie ^a   Xing, Lei ^c   Wu, Hua ^b   Cheng, Zhen ^a  

^a STANFORD UNIVERSITY   (United States)

^b THE FIRST AFFILIATED HOSPITAL OF XIAMEN UNIVERSITY   (China)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5-AMINOLEVULINIC ACID; BRAIN TUMOR IMAGING; FLUORESCENCE IMAGING; FLUORESCENCE IMAGING SYSTEMS; FLUORESCENCE PROBES; FLUORESCENT NANOPARTICLES; NEAR-INFRARED FLUORESCENCE; PHOTO-ACOUSTIC IMAGING;

MOLECULAR IMAGING; NANOPARTICLES; NANOPROBES; NEUROSURGERY; PROBES; TUMORS;

FLUORESCENCE;

AMINOLEVULINIC ACID; FLUORESCEIN SODIUM; NANOPARTICLE;

ANAPHYLAXIS; BRADYCARDIA; BRAIN TISSUE; CANCER SURGERY; FLUORESCENCE IMAGING; GLIOBLASTOMA; HISTOPATHOLOGY; HUMAN; HYPOTENSION; IMAGE GUIDED TUMOR RESECTION; INTRAOPERATIVE PERIOD; LIGHT; MOLECULAR IMAGING; MULTICENTER STUDY (TOPIC); NANOPROBE; NEUROSURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; PHASE 3 CLINICAL TRIAL (TOPIC); PHOTOACOUSTICS; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; SIDE EFFECT; SKIN COLOR; SURGICAL MICROSCOPE; ULTRASOUND; URINE COLOR;

ANIMALS; BRAIN NEOPLASMS; CLINICAL TRIALS AS TOPIC; FLUORESCENCE; GLIOMA; HUMANS; NANOPARTICLES; SURGERY, COMPUTER-ASSISTED;

EID: 84876469091     PISSN: 19395116     EISSN: 19390041     Source Type: Journal    
DOI: 10.1002/wnan.1212     Document Type: Review

References (84)

1. Brandes AA, Tosoni A, Franceschi E, Reni M, Gatta G, Vecht C. Glioblastoma in adults. Crit Rev Oncol Hematol 2008, 67:139-152.
2. Sanai N, Berger MS. Glioma extent of resection and its impact on patient out-come. Neurosurgery 2008, 62:753-764.
3. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005, 352:987-996.
4. Bucci MK, Maity A, Janss AJ, Belasco JB, Fisher MJ, Tochner ZA, Rorke L, Sutton LN, Phillips PC, Shu HK. Near complete surgical resection predicts a favorable outcome in pediatric patients with nonbrainstem, malignant gliomas: results from a single center in the magnetic resonance imaging era. Cancer 2004, 101:817-824.
5. Stupp R, Hegi ME, van den Bent MJ, Mason WP, Weller M, Mirimanoff RO, Cairncross JG. European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group. Changing paradigms-an update on the multidisciplinary management of malignant glioma. Oncologist 2006, 11:165-180.
6. Chien CY, Chuang HC, Huang SH, Lin WC, Huang HY. A pilot study of segmental mandibulectomy with surgical navigation using fluorine-18 fluorodeoxyglucose positron-emission tomography/computed tomography. Laryngoscope 2012, 29:447-452.
7. Bunschoten A, Buckle T, Visser NL, Kuil J, Yuan H, Josephson L, Vahrmeijer AL, van Leeuwen FW. Multimodal interventional molecular imaging of tumor margins and distant metastases by targeting αvβ3 integrin. Chembiochem 2012, 13:1039-1045.
8. Levman JE, Martel AL. A margin sharpness measurement for the diagnosis of breast cancer from magnetic resonance imaging examinations. Acad Radiol 2011, 18:1577-1581.
9. Price SJ, Jena R, Burnet NG, Hutchinson PJ, Dean AF, Peña A, Pickard JD, Carpenter TA, Gillard JH. Improved delineation of glioma margins and regions of infiltration with the use of diffusion tensor imaging: an image-guided biopsy study. AJNR Am J Neuroradiol 2006, 27:1969-1974.
10. Berman JI, Berger MS, Chung SW, Nagarajan SS, Henry RG. Accuracy of diffusion tensor magnetic resonance imaging tractography assesed using intraoperative subcortical stimulation mapping and magnetic source imaging. J Neurosurg 2007, 107:488-494.
11. Konukoglu E, Clatz O, Bondiau PY, Delingette H, Ayache N. Extrapolating tumor invasion margins for physiologically determined radiotherapy regions. Med Image Comput Comput Assist Interv 2006, 9:338-346.
12. Van den Berg NS, van Leeuwen FW, van der Poel HG. Fluorescence guidance in urologic surgery. Curr Opin Urol 2012, 22:109-120.
13. Reinges MH, Nguyen HH, Krings T, Hütter BO, Rohde V, Gilsbach JM. Course of brain shift during microsurgical resection of supratentorial cerebral lesions: limits of conventional neuronavigation. Acta Neurochir (Wien) 2004, 146:369-377.
14. Chacko AG, Kumar NK, Chacko G, Athyal R, Rajshekhar V. Intraoperative ultrasound in determining the extent of resection of parenchymal braintumoursa comparative study with computed tomography and histopathology. Acta Neurochir (Wien) 2003, 145:743-748.
15. Cengiz C, Keramettin A. Intraoperative ultrasonographic characteristics of malignant intracranial lesions. Neurol India 2005, 53:208-211.
16. Kremer P, Tronnier V, Steiner HH, Metzner R, Ebinger F, Rating D, Hartmann M, Seitz A, Unterberg A, Wirtz CR. Intraoperative MRI for interventional neurosurgical procedures and tumor resection control in children. Childs Nerv Syst 2006, 22: 674-678.
17. Bozzao A, Romano A, Angelini A, D'Andrea G, Calabria LF, Coppola V, Mastronardi L, Fantozzi LM, Ferrante L. Identification of the pyramidal tract by neuronavigation based on intraoperative magneticresonance tractography: correlation with subcortical stimulation. Eur Radiol 2010, 20:2475-2481.
18. Hirschberg H, Samset E, Hol PK, Tillung T, Lote K. Impact of intraoperative MRI on the surgical results for high-grade gliomas. Minim Invasive Neurosurg 2005, 48:77-84.
19. Knauth M, Aras N, Wirtz CR, Dörfler A, Engelhorn T, Sartor K. Surgically induced intracranial contrast enhancement: potential source of diagnostic errorin intraoperative MR imaging. AJNR Am J Neuroradiol 1999, 20:1547-1553.
20. Gerganov VM, Samii A, Akbarian A, Stieglitz L, Samii M, Fahlbusch R. Reliability of intraoperative high-resolution 2D ultrasound as an alternative to high-field strength MR imaging for tumor resection control: a prospective comparative study. J Neurosurg 2009, 111: 512-519.
21. Hilderbrand SA, Weissleder R. Near-infrared fluorescence: application to in vivo molecular imaging. Curr Opin Chem Biol 2010, 14:71-79.
22. Frangioni JV. In vivo near-infrared fluorescence imaging. Curr Opin Chem Biol 2003, 7:626-634.
23. Gao J, Chen X, Cheng Z. Near-infrared quantum dots as optical probes for tumor imaging. Curr Top Med Chem 2010, 10:1147-1157.
24. Gao J, Chen K, Miao Z, Ren G, Chen X, Gambhir SS, Cheng Z. Affibody-based nanoprobes for HER2-expressing cell and tumor imaging. Biomaterials 2011, 32:2141-2148.
25. He X, Gao J, Gambhir SS, Cheng Z. Near-infrared fluorescent nanoprobes for cancer molecular imaging: status and challenges. Trends Mol Med 2010, 16:574-583.
26. He X, Wang K, Cheng Z. In vivo near-infrared fluorescence imaging of cancer with nanoparticle-based probes. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2010, 2:349-366.
27. Hellebust A, Richards-Kortum R. Advances in molecular imaging: targeted optical contrast agents for cancer diagnostics. Nanomedicine (Lond) 2012, 7:429-445.
28. Rao J, Dragulescu-Andrasi A, Yao H. Fluorescence imaging in vivo: recent advances. Curr Opin Biotechnol 2007, 18:17-25.
29. Zhang X, Bloch S, Akers W, Achilefu S. Near-infrared molecular probes for in vivo imaging. Curr Protoc Cytom 2012, 12.27:1-20.
30. Ntziachristos V, Bremer C, Weissleder R. Fluorescence imaging with near-infrared light: new technological advances that enable in vivo molecular imaging. Eur Radiol 2003, 13:195-208.
31. Ehrhardt A, Stepp H, Irion KM, Stunner W, Zaak D, Baumgartner R, Hofstetter A. A fluorescence detection of human malignancies using incoherent light systems. Med Laser Appl 2003, 18:27-35.
32. Doiron DR, Profio E, Vincent RG, Dougherty TJ. Fluorescence bronchoscopy for detection of lung cancer. Chest 1979, 76:27-32.
33. Profio AE, Doiron DR. A feasibility study of the use of fluorescence bronchoscopy for localization of small lung tumours. Phys Med Biol 1977, 22:949-957.
34. Kato H, Cortese DA. Early detection of lung cancer by means of hematoporphyrin derivative fluorescence and laser photoradiation. Clin Chest Med 1985, 6:237-253.
35. Profio AE, Doiron DR, Balchum OJ, Huth GC. Fluorescence bronchoscopy for localization of carcinomain situ. Med Phys 1983, 10:35-39.
36. Stummer W, Stocker S, Wagner S, Stepp H, Fritsch C, Goetz C, Goetz AE, Kiefmann R, Reulen HJ. Intraoperative detection of malignant gliomas by 5-amino-levulinic acid-induced porphyrin fluorescence. Neurosurgery 1998, 42:518-525.
37. De Grand AM, Frangioni JV. An operational near-infrared fluorescence imaging system prototype for large animal surgery. Technol Cancer Res Treat 2003, 2: 553-562.
38. Troyan SL, Kianzad V, Gibbs-Strauss SL, Gioux S, Matsui A, Oketokoun R, Ngo L, Khamene A, Azar F, Frangioni JV. The FLARE intraoperative near-infrared fluorescence imaging system: a first-in-human clinical trial in breast cancer sentinel lymph node mapping. Ann Surg Oncol 2009, 16:2943-2952.
39. Bogaards A, Varma A, Collens SP, Lin A, Giles A, Yang VX, Bilbao JM, Lilge LD, Muller PJ, Wilson BC. Increased brain tumor resection using fluorescence image guidance in a preclinical model. Lasers Surg Med 2004, 35:181-190.
40. Sun Y, Hatami N, Yee M, Phipps J, Elson DS, Gorin F, Schrot RJ, Marcu L. Fluorescence lifetime imaging microscopy for brain tumor image-guided surgery. J Biomed Opt 2010, 15:056022.
41. De la Zerda A, Zavaleta C, Keren S, Vaithilingam S, Bodapati S, Liu Z, Levi J, Smith BR, Ma TJ, Oralkan O, et al. Carbon nanotubes as photoacoustic molecular imaging agents in living mice. Nat Nanotechnol 2008, 3:557-562.
42. Wang LV. Multiscale photoacoustic microscopy and computed tomography. Nat Photonics 2009, 3:503-509.
43. Lu W, Huang Q, Ku G, Wen X, Zhou M, Guzatov D, Brecht P, Su R, Oraevsky A, Wang LV, et al. Photoacoustic imaging of living mouse brain vasculature using hollow gold nanospheres. Biomaterials 2010, 31:2617-2626.
44. Kircher MF, de la Zerda A, Jokerst JV, Zavaleta CL, Kempen PJ, Mittra E, Pitter K, Huang R, Campos C, Habte F, et al. A brain tumor molecular imaging strategy using a new triple-modality MRI-photoacoustic-Raman nanoparticle. Nat Med 2012, 18:829-834.
45. Lu W, Melancon MP, Xiong C, Huang Q, Elliott A, Song S, Zhang R, Flores LG 2nd, Gelovani JG, Wang LV, et al. Effects of photoacoustic imaging and photothermal ablation therapy mediated by targeted hollow gold nanospheres in an orthotopic mouse xenograft model of glioma. Cancer Res 2011, 71: 6116-6121.
46. Verbeek FP, van der Vorst JR, Schaafsma BE, Hutteman M, Bonsing BA, van Leeuwen FW, Frangioni JV, van de Velde CJ, Swijnenburg RJ, Vahrmeijer AL. Image-guided hepatopancreatobiliary surgery using near-infrared fluorescent light. J Hepatobiliary Pancreat Sci 2012, 19:626-637. Doi: 10.1007/S00534-012-0534-6.
47. Okuda T, Kataoka K, Taneda M. Metastatic brain tumor surgery using fluorescein sodium: technical note. Minim Invasive Neurosurg 2007, 50:382-384.
48. Shinoda J, Yano H, Yoshimura S, Okumura A, Kaku Y, Iwama T, Sakai N. Fluorescence-guided resection of glioblastoma multiforme by using high-dose fluorescein sodium. J Neurosurg 2003, 99:597-603.
49. Dilek O, Ihsan A, Tulay H. Anaphylactic reaction after fluorescein sodium administration during intracranial surgery. J Clin Neurosci 2011, 18:430-431.
50. Tanahashi S, Lida H, Dohi S. An anaphylactoid reaction after administration of fluorescein sodium during neurosurgery. Anesth Analg 2006, 103:503.
51. Okuda T, Kataoka K, Yabuuchi T, Yugami H, Kato A. Fluorescence-guided surgery of metastatic brain tumors using fluorescein sodium. J Clin Neurosci 2010, 17:118-1121.
52. Nguyen NQ, Biankin AV, Leong RW, Chang DK, Cosman PH, Delaney P, Kench JG, Merrett ND. Real time intraoperative confocal laser microscopy-guided surgery. Ann Surg 2009, 249:73.
53. Kajimoto Y, Miyatake SI, Kuroiwa T. T Fiber-optic spectroscopic detection of neoplasm by intraoperative fluorescence labeling. Int Cong Series 2004, 1259: 33-38.
54. Ichioka T, Miyatake S, Asai N, Kajimoto Y, Nakagawa T, Hayashi H, Kuroiwa T. et al Enhanced detection of malignant glioma xenograft by fluorescein-human serum albumin conjugate. J Neurooncol 2004, 67:47-52.
55. Krammer B, Plaetzer K. ALA and its clinical impact, from bench to bedside. Photochem Photobiol Sci 2008, 7:283-289.
56. Musiol R, Serda M, Polanski J. Prodrugs in photodynamic anticancer therapy. Curr Pharm Des 2011, 17: 3548-3559.
57. Hebeda KM, Saarnak AE, Olivo M, Sterenborg HJCM, Wolber JG. 5-aminolevulinic acid induced endogenous porphyrin fluorescence in 9L and C6 brain tumors and in the normal brain. Acta Neurochir (Wien) 1998, 140: 503-513.
58. Eléouet S, Rousset N, Carré J, Bourré L, Vonarx V, Lajat Y, Beijersbergen van Henegouwen GM, Patrice T. In vitro fluorescence, toxicity and phototoxicity induced by delta-aminolevulinic acid (ALA) or ALA-esters. Photochem Photobiol 2000, 71:447-454.
59. Stummer W, Novotny A, Stepp H, Goetz C, Bise K, Reulen HJ. Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: a prospective study in 52 consecutive patients. J Neurosurg 2000, 93:1003-1013.
60. Hefti M, Mehdorn HM, Albert I, Dorner L. Fluorescence-guided surgery for malignant glioma: a review on aminolevulinic acid induced protoporphyrin IX photodynamic diagnostic in brain tumors. Curr Med Imag Rev 2010, 6:254-258(5).
61. Divaris DX, Kennedy JC, Pottier RH. Phototoxic damage to sebaceous glands and hair follicles of mice after systemic administration of 5-aminolevulinic acid correlates with localized protoporphyrin IX fluorescence. Am J Pathol 1990, 136:891-897.
62. Jokerst JV, Gambhir SS. Molecular imaging with theranostic nanoparticles. Acc Chem Res 2011, 44:1050-1060.
63. Artemov D, Mori N, Okollie B, Bhujwalla ZM. MR molecular imaging of the Her-2/neu receptor in breast cancer cells using targeted iron oxide nanoparticles. Magn Reson Med 2003, 49:403-408.
64. Yang X, Stein EW, Ashkenazi S, Wang LV. Nanoparticles for photoacoustic imaging. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2009, 1:360-368.
65. Cai W, Shin DW, Chen K, Gheysens O, Cao Q, Wang SX, Gambhir SS, Chen X. Peptide-labeled near-infrared quantum dots for imaging tumor vasculature in living subjects. Nano Lett 2006, 6:669-676.
66. Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen HJ, ALA-Glioma Study Group. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 2006, 7:392-401.
67. Kremer P, Fardanesh M, Ding R, Pritsch M, Zoubaa S, Frei E. Intraoperative fluorescence staining of malignant brain tumors using 5-aminofluorescein-labeled albumin. Neurosurgery 2009, 64:ons53-60.
68. Kircher MF, Mahmood U, King RS, Weissleder R, Josephson L. A multimodal nanoparticle for preoperative magnetic resonance imaging and intraoperative optical brain tumor delineation. Cancer Res 2003, 63: 8122-8125.
69. Lee JH, Huh YM, Jun YW, Seo JW, Jang JT, Song HT, Kim S, Cho EJ, Yoon HG, Suh JS, et al. Artificially engineered magnetic nanoparticles for ultrasensitive molecular imaging. Nat Med 2007, 13:95-99.
70. Yang L, Mao H, Cao Z, Wang YA, Peng X, Wang X, Sajja HK, Wang L, Duan H, Ni C, et al. Molecular imaging of pancreatic cancer in an animal model using targeted multifunctional nanoparticles. Gastroenterology 2009, 136:1514-1525.e2.
71. Veiseh O, Sun C, Gunn J, Kohler N, Gabikian P, Lee D, Bhattarai N, Ellenbogen R, Sze R, Hallahan A, et al. Optical and MRI multifunctional nanoprobe for targeting gliomas. Nano Lett 2005, 5:1003-1008.
72. Veiseh O, Sun C, Fang C, Bhattarai N, Gunn J, Kievit F, Du K, Pullar B, Lee D, Ellenbogen RG, et al. Specific targeting of brain tumors with an optical/magnetic resonance imaging nanoprobe across the blood-brain barrier. Cancer Res 2009, 69:6200-6207.
73. Yan H, Wang L, Wang J, Weng X, Lei H, Wang X, Jiang L, Zhu J, Lu W, Wei X, et al. Two-order targeted brain tumor imaging by using an optical/paramagnetic nanoprobe across the blood brain barrier. ACS Nano 2012, 6:410-420.
74. Towner RA, Smith N, Asano Y, He T, Doblas S, Saunders D, Silasi-Mansat R, Lupu F, Seeney CE. Molecular magnetic resonance imaging approaches used to aid in the understanding of angiogenesis in vivo: implications for tissue engineering. Tissue Eng Part A 2010, 16: 357-364.
75. Terwisscha van Scheltinga AG, van Dam GM, Nagengast WB, Ntziachristos V, Hollema H, Herek JL, Schröder CP, Kosterink JG, Lub-de Hoog MN, de Vries EG. Intraoperative near-infrared fluorescence tumor imaging with vascular endothelial growth factorand human epidermal growth factor receptor 2 targeting anti-bodies. J Nucl Med 2011, 52:1778-1785.
76. 3-integrin targeted near-infrared fluorescent agent. Ann Surg Oncol 2011, 18:3506-3513.
77. Hak S, Helgesen E, Hektoen HH, Huuse EM, Jarzyna PA, Mulder WJ, Haraldseth O, Davies Cde L. The effect of nanoparticle polyethylene glycol surface density on ligand-directed tumor targetingstudied in vivo by dual modality imaging. ACS Nano 2012, 6:5648-5658.
78. Yang VX, Muller PJ, Herman P, Wilson BC. A multispectral fluorescence imaging system: design and initial clinical tests in intra-operative photofrin-photodynamic therapy of brain tumors. Lasers Surg Med 2003, 32:224-232.
79. Kumar AT, Raymond SB, Bacskai BJ, Boas DA. Comparison of frequency-domain and time-domain fluorescence lifetime tomography. Opt Lett 2008, 33: 470-472.
80. Mazhar A, Dell S, Cuccia DJ, Gioux S, Durkin AJ, Frangioni JV, Tromberg BJ. Wavelength optimization for rapid chromophore mapping using spatial frequency domain imaging. J Biomed Opt 2010, 15:061716.
81. Valdés PA, Leblond F, Kim A, Harris BT, Wilson BC, Fan X, Tosteson TD, Hartov A, Ji S, Erkmen K, et al. Quantitative fluorescence in intracranial tumor: implications for ALA-induced PpIX as an intraoperative biomarker. J Neurosurg 2011, 115:11-17.
82. Li C, Yang Y, Mitchell GS, Cherry SR. Simultaneous PET and multispectral 3-dimensional fluorescence optical tomography imaging system. J Nucl Med 2011, 52:1268-1275.
83. Brouwer OR, Buckle T, Bunschoten A, Kuil J, Vahrmeijer AL, Wendler T, Valdés-Olmos RA, van der Poel HG, van Leeuwen FW. Image navigation as a means to expand the boundaries of fluorescence-guided surgery. Phys Med Biol 2012, 57:3123-3136.
84. Xi L, Grobmyer SR, Wu L, Chen R, Zhou G, Gutwein LG, Sun J, Liao W, Zhou Q, Xie H, et al. Evaluation of breast tumor margins in vivo with intraoperative photoacoustic imaging. Opt Express 2012, 20:8726-8731.